pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,883 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06002789: Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: PHASE2. Conditions: Multiple Cancer, Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07473089: Swiss Revision Cohort

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Joint (Knee or Hip Replacement), Infection as Complication of Medical Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT06581068: Automation of the In Vitro Fertilization Laboratory

Sponsor: Conceivable Life Sciences. Phase: NA. Conditions: Infertility, ART

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07468591: Spinal Cord Stimulation for Refractory Pain Randomized Controlled Trial: the PAcStim RCT

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Chronic Pain Syndrome

full page →ctgov ↗
›WITHHELDphase readoutNCT07168174: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT07233213: An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd.. Phase: PHASE3. Conditions: Primary Immune Thrombocytopenia (ITP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06848660: Study on Orthosis in Cervical Spine Fracture Treatment

Sponsor: Uppsala University Hospital. Phase: NA. Conditions: Cervical Spine Fractures, Cervical Spine Injury, Rigid Collar

full page →ctgov ↗
›RECRUITINGphase readoutNCT07428460: Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

Sponsor: Douglas Mental Health University Institute. Phase: NA. Conditions: Schizophrenia and Predominant Negative Symptoms

full page →ctgov ↗
›WITHDRAWNphase readoutNCT05829460: Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Endometrial Hyperplasia

full page →ctgov ↗
›WITHHELDphase readoutNCT07524660: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT06818760: Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables

Sponsor: The Cleveland Clinic. Phase: . Conditions: Congenital Heart Disease, Congenital Vascular Disorder, Congenital Cardiomyopathy, Pregnancy Related

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07398560: Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

Sponsor: The Third Affiliated Hospital of Harbin Medical University. Phase: PHASE2. Conditions: Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06986460: Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression

Sponsor: Tyler Kaster. Phase: PHASE3. Conditions: Bipolar Depression Depressed Phase

full page →ctgov ↗
›RECRUITINGphase readoutNCT05471960: Neuroplasticity in RBD

Sponsor: University of Minnesota. Phase: NA. Conditions: REM Sleep Behavior Disorder

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06560021: Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: NA. Conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05724121: Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia, Mantle Cell Lymphoma, Sudden Cardiac Death, Cardiac Arrhythmias, Hematologic Malignancies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02656706: Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma

Sponsor: Brown University. Phase: PHASE2. Conditions: Melanoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07430904: Empowerment Program to Reduce Treatment of Asymptomatic Bacteriuria in Veterans With Spinal Cord Injury

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Spinal Cord Injury, Spinal Cord Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07095933: The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

Sponsor: Xuanwu Hospital, Beijing. Phase: EARLY_PHASE1. Conditions: Epilepsy, Drug Resistant

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06161584: A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Sponsor: Apellis Pharmaceuticals, Inc.. Phase: . Conditions: Geographic Atrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07509333: MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients

Sponsor: West China Hospital. Phase: NA. Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Elderly

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07448233: Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas

Sponsor: Xijing Hospital. Phase: NA. Conditions: Epilepsies, Remote Management of Epilepsy in Rural Areas

full page →ctgov ↗
›COMPLETEDphase readoutNCT02410733: Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma

Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT04128748: Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Blasts More Than 10 Percent of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia, Refractory Myelodysplastic Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07144826: Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma, Stage II Ovarian Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06206226: The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot Study

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Depression, Depressive Disorder, Depressive Symptoms

full page →ctgov ↗
›COMPLETEDphase readoutNCT05116085: Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer

Sponsor: BeiGene. Phase: PHASE2. Conditions: Colorectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07512115: The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surgery?

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: NA. Conditions: Myopia, Refractive Ametropia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07532915: A Multicenter, Prospective, Randomized Controlled Study on EUS-Guided Precise Disconnection of Varices Versus Endoscopic Gastric Variceal Glue Injection for the Prevention of Gastric Variceal Bleeding.

Sponsor: Nanfang Hospital, Southern Medical University. Phase: NA. Conditions: Gastric Variceal

full page →ctgov ↗
›COMPLETEDphase readoutNCT00893035: Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: . Conditions: Breast Cancer, Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07324408: Multiple Ascending Dose Study of NH102 in Healthy Subjects

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT06760208: A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

Sponsor: Pfizer. Phase: . Conditions: Pneumococcal Immunization, Safety

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07337408: Characterization of Weaning Practices in ICUs of Global South Countries

Sponsor: Hospital do Coracao. Phase: . Conditions: Weaning From Mechanical Ventilation, Weaning Failure, Weaning From Mechanical Ventilation, Extubation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07542925: Prediction of Postoperative ICU Requirement in Oncologic Surgery

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Neoplasms, Postoperative Complications, Perioperative/Postoperative Complications, Intensive Care Units

full page →ctgov ↗
›RECRUITINGphase readoutNCT07232576: A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE2. Conditions: Adult Patients With Moderately to Severely Active Ulcerative Colitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06357676: Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

Sponsor: OHSU Knight Cancer Institute. Phase: PHASE1. Conditions: Mantle Cell Lymphoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07038317: A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status

Sponsor: University of Hawaii. Phase: NA. Conditions: Vaping Behaviors, Message Exposure, Young Adults

full page →ctgov ↗
›COMPLETEDphase readoutNCT06614140: Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Sponsor: Seqker Biosciences, Inc.. Phase: PHASE1. Conditions: Cancer, Solid Tumor, Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT07323589: Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS

Sponsor: PAEC general hospital. Phase: PHASE3. Conditions: PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07202650: THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME

Sponsor: Baskent University. Phase: NA. Conditions: Guided Imagery, Premenstrual Syndrome, Nursing

full page →ctgov ↗
›COMPLETEDphase readoutNCT01765374: Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

Sponsor: University Hospital, Rouen. Phase: PHASE4. Conditions: Rheumatoid Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05436418: The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04626518: Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Carcinoma, Renal Cell

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07074418: Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE4. Conditions: Chronic Kidney Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06121297: RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Sponsor: Cabaletta Bio. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus, Lupus Nephritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07314710: Factors Affecting Postural Awareness in Academics

Sponsor: Kutahya Health Sciences University. Phase: . Conditions: Health Adult Subjects

full page →ctgov ↗
›COMPLETEDphase readoutNCT07478913: Predictive Value of Endobronchial Sonographic Patterns in Diagnosis of Mediastinal Lymphadenopathy

Sponsor: Ain Shams University. Phase: . Conditions: Endobronchial Sonographic Patterns

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427420: Postoperative Pain After Pulpectomy in Primary Molars

Sponsor: Cairo University. Phase: NA. Conditions: Irreversible Pulpitis

full page →ctgov ↗
›TERMINATEDphase readoutNCT06487858: A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

Sponsor: BeOne Medicines. Phase: PHASE1. Conditions: Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07343258: Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline

Sponsor: University Ghent. Phase: NA. Conditions: Suicide, Suicidal Ideation and Behavior, Crisis Intervention

full page →ctgov ↗
← prev
page 70 of 158
next →